20/10/2026
TOKAI's product development has consistently been driven by a single ambition: understanding how light interacts with the eye and engineering lenses that protect the eye from its harmful effects.
MYOGEN applies that same philosophy to a different challenge: not the spectral quality of light, but its direction. By controlling the travelling direction of light through TOKAI's proprietary honeycomb structure and special lens surface shape, MYOGEN works to suppress the eye axis elongation that drives myopia progression in children.
MYOGEN is a clinical response to one of the most significant eye health challenges of our generation.